Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1985 May;53(5):488–492. doi: 10.1136/hrt.53.5.488

Improvement in angina pectoris with alpha adrenoceptor blockade.

P Collins, D Sheridan
PMCID: PMC481798  PMID: 2859870

Abstract

The effects of indoramin, a selective alpha 1 adrenoceptor antagonist, on exercise tolerance were studied in 15 patients using a random double blind crossover protocol. All patients had chronic stable angina, for which 13 had been receiving beta adrenoceptor blocking drugs and nitrates, and these were continued unchanged throughout the study. An initial open challenge with indoramin in eight patients with chronic stable angina showed no serious adverse effects. In a dose of 25 mg three times daily indoramin prolonged exercise duration and increased oxygen consumption during exercise, while the maximal double product was unchanged. The increased exercise capacity was associated with a reduction in ST segment depression during exercise. Side effects included failure of ejaculation in one patient and tiredness in five. These results indicate than alpha 1 adrenoceptor blockade may provide useful additional benefit to patients with stable angina pectoris who are already receiving beta blockers and nitrates.

Full text

PDF
488

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum T., Shropshire A. T., Eckfeld D. K., Metz N., Dinish J. L., Peters J. R., Butz F., Gluckman M. I. Studies relating to the antihypertensive and antidysrhythmic action of indoramin. Arch Int Pharmacodyn Ther. 1973 Aug;204(2):390–406. [PubMed] [Google Scholar]
  2. Brittain R. T., Levy G. P. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681–684. [PubMed] [Google Scholar]
  3. Bruce R. A., Hornsten T. R. Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis. 1969 Mar;11(5):371–390. doi: 10.1016/0033-0620(69)90027-9. [DOI] [PubMed] [Google Scholar]
  4. Coleman A. J., Leary W. P., Asmal A. C. Cardiovascular effects of intravenous indoramin hydrochloride in man. J Int Med Res. 1979;7(6):511–518. doi: 10.1177/030006057900700606. [DOI] [PubMed] [Google Scholar]
  5. Dawson J. R., Whitaker N. H., Sutton G. C. Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine. Br Heart J. 1981 Nov;46(5):508–512. doi: 10.1136/hrt.46.5.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gould B. A., Mann S., Davies A. B., Altman D. G., Raftery E. B. Alpha-adrenoreceptor blockade with indoramin in hypertension. J Cardiovasc Pharmacol. 1983 May-Jun;5(3):343–348. doi: 10.1097/00005344-198305000-00001. [DOI] [PubMed] [Google Scholar]
  7. Gould B. A., Mann S., Davies A. B., Altman D. G., Raftery E. B. Alpha-adrenoreceptor blockade with indoramin in hypertension. J Cardiovasc Pharmacol. 1983 May-Jun;5(3):343–348. doi: 10.1097/00005344-198305000-00001. [DOI] [PubMed] [Google Scholar]
  8. Halprin S., Frishman W., Kirschner M., Strom J. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience. Am Heart J. 1980 Mar;99(3):388–396. doi: 10.1016/0002-8703(80)90354-3. [DOI] [PubMed] [Google Scholar]
  9. McNeil J. J., Louis W. J. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension. Br J Clin Pharmacol. 1979;8(Suppl 2):163S–166S. [PMC free article] [PubMed] [Google Scholar]
  10. Olivari M. T., Garberg V. R., Selby T., Cohn J. N., Levine T. B. Acute hemodynamic and hormonal response to indoramin in congestive heart failure. Clin Pharmacol Ther. 1984 Sep;36(3):297–301. doi: 10.1038/clpt.1984.178. [DOI] [PubMed] [Google Scholar]
  11. Whiting P. H., Barber H. E., Petersen J. The effect of frusemide and piretanide on the renal clearance of gentamicin in man. Br J Clin Pharmacol. 1981 Dec;12(6):795–799. doi: 10.1111/j.1365-2125.1981.tb01309.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Winniford M. D., Filipchuk N., Hillis L. D. Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial. Circulation. 1983 Jun;67(6):1185–1188. doi: 10.1161/01.cir.67.6.1185. [DOI] [PubMed] [Google Scholar]
  13. Winniford M. D., Huxley R. L., Hillis L. D. Randomized, double-blind comparison of propranolol alone and a propranolol-verapamil combination in patients with severe angina of effort. J Am Coll Cardiol. 1983 Feb;1(2 Pt 1):492–498. doi: 10.1016/s0735-1097(83)80078-3. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES